Search research articles
Contact Us
Filters
Showing results (1121-1130 of 1,160) with videos related to
Page
of 116
Sort By:
American Journal of Hematology
|
March 15, 2026
Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia
Jorge J Castillo, Andrew R Branagan, Alberto Guijosa, et al.
Implementation Science : IS
|
July 31, 2020
The effects of a prolonged exposure workshop with and without consultation on provider and patient outcomes: a randomized implementation trial
Edna B Foa, Carmen P McLean, Lily A Brown, et al.
Blood
|
January 25, 2008
CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia
Allen W Ho, Evdoxia Hatjiharissi, Bryan T Ciccarelli, et al.
American Journal of Human Genetics
|
January 9, 2008
Admixture mapping of white cell count: genetic locus responsible for lower white blood cell count in the Health ABC and Jackson Heart studies
Michael A Nalls, James G Wilson, Nick J Patterson, et al.
Blood
|
November 5, 2008
Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia
Xavier Leleu, Lian Xu, Xiaoying Jia, et al.
Haematologica
|
October 21, 2016
Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome
Monique C Minnema, Eva Kimby, Shirley D'Sa, et al.
Seminars in Hematology
|
May 22, 2025
Report of Consensus Panel 1 from the 12th International Workshop on the management of patients with IgM and Waldenstrom's Macroglobulinemia related neuropathy
Shirley D'Sa, Jahanzaib Khwaja, Signy Chow, et al.
Blood
|
January 17, 2013
MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction
Lian Xu, Zachary R Hunter, Guang Yang, et al.
Blood
|
March 3, 2018
BTK<sup>Cys481Ser</sup> drives ibrutinib resistance via ERK1/2 and protects BTK<sup>wild-type</sup> MYD88-mutated cells by a paracrine mechanism
Jiaji G Chen, Xia Liu, Manit Munshi, et al.
Seminars in Hematology
|
May 16, 2025
Report of Consensus Panel 5 from the 12th International Workshop on Waldenström's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors
Jorge J Castillo, Francesco Autore, Neil L Berinstein, et al.
Page
of 116
Search research articles
Search
Showing results (1121-1130 of 1,160) with videos related to
Sort By:
Page
of 116
American Journal of Hematology
|
March 15, 2026
Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia
Jorge J Castillo, Andrew R Branagan, Alberto Guijosa, et al.
Implementation Science : IS
|
July 31, 2020
The effects of a prolonged exposure workshop with and without consultation on provider and patient outcomes: a randomized implementation trial
Edna B Foa, Carmen P McLean, Lily A Brown, et al.
Blood
|
January 25, 2008
CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia
Allen W Ho, Evdoxia Hatjiharissi, Bryan T Ciccarelli, et al.
American Journal of Human Genetics
|
January 9, 2008
Admixture mapping of white cell count: genetic locus responsible for lower white blood cell count in the Health ABC and Jackson Heart studies
Michael A Nalls, James G Wilson, Nick J Patterson, et al.
Blood
|
November 5, 2008
Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia
Xavier Leleu, Lian Xu, Xiaoying Jia, et al.
Haematologica
|
October 21, 2016
Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome
Monique C Minnema, Eva Kimby, Shirley D'Sa, et al.
Seminars in Hematology
|
May 22, 2025
Report of Consensus Panel 1 from the 12th International Workshop on the management of patients with IgM and Waldenstrom's Macroglobulinemia related neuropathy
Shirley D'Sa, Jahanzaib Khwaja, Signy Chow, et al.
Blood
|
January 17, 2013
MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction
Lian Xu, Zachary R Hunter, Guang Yang, et al.
Blood
|
March 3, 2018
BTK<sup>Cys481Ser</sup> drives ibrutinib resistance via ERK1/2 and protects BTK<sup>wild-type</sup> MYD88-mutated cells by a paracrine mechanism
Jiaji G Chen, Xia Liu, Manit Munshi, et al.
Seminars in Hematology
|
May 16, 2025
Report of Consensus Panel 5 from the 12th International Workshop on Waldenström's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors
Jorge J Castillo, Francesco Autore, Neil L Berinstein, et al.
Page
of 116